Zhihai Li

8PUBLICATIONS
29CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesMolecular targetsStructural properties of condensed matter
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 14, 2026
Discovery of the First-in-Class Protein Arginine Methyltransferase 1 PROTAC Degrader.

Siqi Guo, Jianhao Li, Junjie Lin

|Jan 19, 2026
Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery.

Chongbin Bai, Zhanpeng Miao, Mengting Yuan

|May 07, 2025
Fluorescence-Coupled Ubiquitination Assay as a High-Throughput Screening Strategy for Novel Cereblon Degraders.

Yanan Deng, Shiling Yang, Hesong Xu

|Sep 12, 2024
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity.

Yingjie Chang, Huahui Guo, Xue Li

|Jul 28, 2021
Structural basis for genome packaging, retention, and ejection in human cytomegalovirus.

Zhihai Li, Jingjing Pang, Lili Dong

|Mar 06, 2021
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.

Wanchao Yin, Xiaodong Luan, Zhihai Li

Pageof 2

Frequent Collaborators

3 joint publications

Xuekui Yu

3 joint publications

Cheng Luo

2 joint publications

Wanchao Yin

2 joint publications

Fei Ye